ArchiMed
PE
2014
$9 000 M
New York, New York, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Animal & Environmental Health, Healthcare IT, Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.
ARCHIMED manages €9 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner.
Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.
Industry
Region of investment
ArchiMed Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
MED I
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
SaaS
Software
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$155 M
|
December 2014
|
